Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-20

Clinical Trial Update: Amiloride Hydrochloride as an Effective Treatment for ADHD [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial evaluating amiloride hydrochloride for attention-deficit/hyperactivity disorder was terminated, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMILORIDE HYDROCHLORIDE (AMILORIDE HYDROCHLORIDE)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: ADHD | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2018-07-20